Dominic P. Behan
2012
In 2012, Dominic P. Behan earned a total compensation of $2.2M as Executive Vice President, Chief Scientific Officer and Director at Arena Pharmaceuticals, a 160% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $240,000 |
|---|---|
| Option Awards | $1,289,200 |
| Salary | $400,000 |
| Stock Awards | $266,100 |
| Other | $15,636 |
| Total | $2,210,936 |
Behan received $1.3M in option awards, accounting for 58% of the total pay in 2012.
Behan also received $240K in non-equity incentive plan, $400K in salary, $266.1K in stock awards and $15.6K in other compensation.
Rankings
In 2012, Dominic P. Behan's compensation ranked 3,224th out of 11,487 executives tracked by ExecPay. In other words, Behan earned more than 71.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,224 out of 11,487 | 72nd |
Division Manufacturing | 1,118 out of 4,253 | 74th |
Major group Chemicals And Allied Products | 249 out of 1,198 | 79th |
Industry group Drugs | 146 out of 920 | 84th |
Industry Pharmaceutical Preparations | 118 out of 700 | 83rd |
Source: SEC filing on April 29, 2015.
Behan's colleagues
We found four more compensation records of executives who worked with Dominic P. Behan at Arena Pharmaceuticals in 2012.